JP2008540563A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540563A5 JP2008540563A5 JP2008511366A JP2008511366A JP2008540563A5 JP 2008540563 A5 JP2008540563 A5 JP 2008540563A5 JP 2008511366 A JP2008511366 A JP 2008511366A JP 2008511366 A JP2008511366 A JP 2008511366A JP 2008540563 A5 JP2008540563 A5 JP 2008540563A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- composition
- nebulizer
- mutated
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/127,438 US20050271660A1 (en) | 2002-09-06 | 2005-05-11 | Nebulization of monoclonal antibodies for treating pulmonary diseases |
| PCT/US2006/018269 WO2006122257A2 (en) | 2005-05-11 | 2006-05-10 | Nebulization of monoclonal antibodies for treating pulmonary diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012193985A Division JP2012233013A (ja) | 2005-05-11 | 2012-09-04 | 肺疾患を処置するためのモノクローナル抗体の霧状化 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008540563A JP2008540563A (ja) | 2008-11-20 |
| JP2008540563A5 true JP2008540563A5 (https=) | 2009-06-04 |
Family
ID=37054603
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008511366A Withdrawn JP2008540563A (ja) | 2005-05-11 | 2006-05-10 | 肺疾患を処置するためのモノクローナル抗体の霧状化 |
| JP2012193985A Pending JP2012233013A (ja) | 2005-05-11 | 2012-09-04 | 肺疾患を処置するためのモノクローナル抗体の霧状化 |
| JP2014125985A Pending JP2014169332A (ja) | 2005-05-11 | 2014-06-19 | 肺疾患を処置するためのモノクローナル抗体の霧状化 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012193985A Pending JP2012233013A (ja) | 2005-05-11 | 2012-09-04 | 肺疾患を処置するためのモノクローナル抗体の霧状化 |
| JP2014125985A Pending JP2014169332A (ja) | 2005-05-11 | 2014-06-19 | 肺疾患を処置するためのモノクローナル抗体の霧状化 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US20050271660A1 (https=) |
| EP (1) | EP1881993A2 (https=) |
| JP (3) | JP2008540563A (https=) |
| AU (1) | AU2006243994B2 (https=) |
| CA (1) | CA2608195A1 (https=) |
| NZ (2) | NZ582627A (https=) |
| WO (1) | WO2006122257A2 (https=) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050271660A1 (en) | 2002-09-06 | 2005-12-08 | Alexion Pharmaceuticals, Inc. | Nebulization of monoclonal antibodies for treating pulmonary diseases |
| WO2004022096A1 (en) * | 2002-09-06 | 2004-03-18 | Alexion Pharmaceuticals, Inc. | Method of treatment of asthma using antibodies to complement component c5 |
| US9415102B2 (en) | 2002-09-06 | 2016-08-16 | Alexion Pharmaceuticals, Inc. | High concentration formulations of anti-C5 antibodies |
| WO2010081856A1 (en) * | 2009-01-14 | 2010-07-22 | Ablynx Nv | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| US9320792B2 (en) | 2002-11-08 | 2016-04-26 | Ablynx N.V. | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
| WO2005048982A2 (en) * | 2003-11-17 | 2005-06-02 | Nektar Therapeutics | Efficient introduction of an aerosol into a ventilator circuit |
| ES2432112T3 (es) | 2004-02-10 | 2013-11-29 | The Regents Of The University Of Colorado, A Body Corporate | Inhibición del factor B, de la vía alternativa del complemento y métodos relacionados |
| DK1817340T3 (da) | 2004-11-12 | 2012-08-13 | Xencor Inc | Fc-varianter med ændret binding til fcrn |
| CA2610340C (en) | 2005-05-26 | 2016-02-16 | Vernon Michael Holers | Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| US20070191262A1 (en) * | 2005-11-15 | 2007-08-16 | University Of Iowa Research Foundation | Cancer Therapy and Prevention Based on Modulation of Complement activity |
| PL3167888T3 (pl) | 2006-03-15 | 2024-08-26 | Alexion Pharmaceuticals, Inc. | Leczenie pacjentów z napadową nocną hemoglobinurią za pomocą inhibitora dopełniacza |
| PL2061501T3 (pl) * | 2006-09-08 | 2016-01-29 | Volution Immuno Pharmaceuticals Sa | Sposób leczenia zaburzeń oddechowych |
| US8312879B2 (en) * | 2006-10-16 | 2012-11-20 | General Electric Company | Method and apparatus for airway compensation control |
| CA2680344A1 (en) | 2007-03-14 | 2008-11-20 | Woodruff Emlen | Humaneered anti-factor b antibody |
| RU2529951C2 (ru) * | 2007-12-26 | 2014-10-10 | Ксенкор, Инк. | ВАРИАНТЫ Fc С ИЗМЕНЕННЫМ СВЯЗЫВАНИЕМ C FcRn |
| EP2254411A4 (en) * | 2008-02-19 | 2012-06-13 | Univ Pennsylvania | COMPLEMENT INHIBITORS AS A THERAPEUTIC FOR THE TREATMENT OF CANCER |
| US12492253B1 (en) | 2008-02-25 | 2025-12-09 | Xencor, Inc. | Anti-human C5 antibodies |
| US20220281964A1 (en) * | 2008-02-25 | 2022-09-08 | Xencor, Inc. | Fc VARIANTS WITH ALTERED BINDING TO FcRn |
| LT2894165T (lt) | 2008-11-10 | 2023-03-10 | Alexion Pharmaceuticals, Inc. | Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui |
| GB0904214D0 (en) * | 2009-03-11 | 2009-04-22 | Ucb Pharma Sa | Biological products |
| EP2427497B1 (fr) | 2009-05-07 | 2016-12-07 | Stallergenes | Utilisation d'immunoglobulines igg1 et/ou de ligands du récepteur cd32 pour le traitement de maladies et manifestations inflammatoires par voie mucosale |
| KR20100123240A (ko) * | 2009-05-15 | 2010-11-24 | 포항공과대학교 산학협력단 | 호흡기 염증성 질환의 치료 또는 예방을 위한 호흡기내 투여용 약학 제제 및 상기 질환의 치료 또는 예방 방법 |
| NZ597259A (en) | 2009-06-23 | 2014-04-30 | Alexion Pharma Inc | Bispecific antibodies that bind to complement proteins |
| JP5871798B2 (ja) | 2009-07-02 | 2016-03-01 | エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント | 肝再生を刺激する方法 |
| CA2786692A1 (en) | 2010-01-11 | 2011-07-14 | Alexion Pharmaceuticals, Inc. | Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies |
| PT3501499T (pt) | 2010-02-11 | 2022-11-22 | Ablynx Nv | Métodos e composições para a preparação de aerossóis |
| EP2824111B1 (en) | 2010-04-30 | 2017-03-22 | Alexion Pharmaceuticals, Inc. | Anti-C5A Antibodies and Methods for Using the Antibodies |
| US9815890B2 (en) | 2010-06-22 | 2017-11-14 | The Regents Of The University Of Colorado, A Body Corporate | Antibodies to the C3d fragment of complement component 3 |
| EP2464346A1 (en) * | 2010-08-30 | 2012-06-20 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| RU2017144619A (ru) | 2010-09-29 | 2019-02-20 | Пулмэтрикс, Инк. | Катионы одновалентных металлов сухих порошков для ингаляций |
| WO2013126006A1 (en) | 2012-02-20 | 2013-08-29 | Swedish Orphan Biovitrum Ab (Publ) | Polypeptides binding to human complement c5 |
| TW201400499A (zh) * | 2012-03-12 | 2014-01-01 | Revo Biolog Inc | 抗凝血酶用於治療妊娠毒血症之用途 |
| EP2855529A4 (en) | 2012-05-24 | 2015-12-09 | Alexion Pharma Inc | HUMANIZED ANTI-FACTOR B ANTIBODIES |
| TW201425332A (zh) | 2012-08-03 | 2014-07-01 | Revo Biolog Inc | 抗凝血酶用於體外膜氧合之用途 |
| CN104870475B (zh) | 2012-10-25 | 2019-11-08 | 美国比奥维拉迪维股份有限公司 | 抗补体C1s抗体和其用途 |
| DK2914291T3 (da) | 2012-11-02 | 2022-05-16 | Bioverativ Usa Inc | Anti-komplement-c1s-antistoffer og anvendelser deraf |
| US20140170158A1 (en) * | 2012-12-17 | 2014-06-19 | The Johns Hopkins University | Compositions and methods for treating or preventing lung diseases |
| ES2768648T3 (es) | 2013-03-29 | 2020-06-23 | Alexion Pharma Inc | Composiciones y métodos para aumentar la semivida en suero de un agente terapéutico dirigido a C5 del complemento |
| JP6473738B2 (ja) | 2013-04-01 | 2019-02-20 | パルマトリックス，インコーポレイテッド | チオトロピウム乾燥粉末 |
| AU2014306002B2 (en) | 2013-08-07 | 2017-05-25 | Alexion Pharmaceuticals, Inc. | Atypical hemolytic uremic syndrome (aHUS) biomarker proteins |
| NZ631007A (en) | 2014-03-07 | 2015-10-30 | Alexion Pharma Inc | Anti-c5 antibodies having improved pharmacokinetics |
| CN106132398A (zh) | 2014-04-03 | 2016-11-16 | 瑞士杰特贝林生物制品有限公司 | 免疫球蛋白的雾化 |
| JP6532034B2 (ja) * | 2015-03-24 | 2019-06-19 | 学校法人関西医科大学 | 鼻腔抵抗の測定方法、鼻腔抵抗及び肺気道抵抗の測定方法及び該方法の実施に用いる測定装置 |
| WO2016164358A1 (en) | 2015-04-06 | 2016-10-13 | True North Therapeutics, Inc. | Humanized anti-c1s antibodies and methods of use thereof |
| WO2016196070A1 (en) | 2015-06-03 | 2016-12-08 | Children's Hospital Medical Center | Compositions and methods for treating neonatal biliary atresia |
| JP2019517473A (ja) | 2016-05-27 | 2019-06-24 | アレクシオン ファーマシューティカルズ インコーポレイテッドＡｌｅｘｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 難治性全身型重症筋無力症の処置のための方法 |
| ES2984352T3 (es) | 2016-06-14 | 2024-10-29 | Regeneron Pharma | Anticuerpos anti-C5 y usos de los mismos |
| HUE073475T2 (hu) | 2016-10-12 | 2026-01-28 | Bioverativ Usa Inc | C1s elleni antitestek és alkalmazási eljárásaik |
| MX2020000435A (es) | 2017-07-14 | 2020-08-17 | Cytomx Therapeutics Inc | Anticuerpos anti-cd166 y usos de estos. |
| SI3658184T1 (sl) | 2017-07-27 | 2024-01-31 | Alexion Pharmaceuticals, Inc., | Formulacije z visoko koncentracijo protiteles proti-C5 |
| CA3080187A1 (en) | 2017-10-26 | 2019-05-02 | Alexion Pharmaceuticals, Inc. | Dosage and administration of anti-c5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (pnh) and atypical hemolytic uremic syndrome (ahus) |
| MA51147A (fr) | 2017-12-13 | 2021-03-24 | Regeneron Pharma | Associations d'anticorps anti-c5 et utilisations associées |
| US11802154B2 (en) | 2017-12-20 | 2023-10-31 | Alexion Pharmaceuticals, Inc. | Humanized anti-CD200 antibodies and uses thereof |
| US12404320B2 (en) | 2018-05-31 | 2025-09-02 | Alexion Pharmaceuticals, Inc. | Dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH) in pediatric patients |
| JP7577542B2 (ja) | 2018-06-04 | 2024-11-05 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 小児患者における非典型溶血性尿毒症症候群（ａＨＵＳ）の治療のための抗Ｃ５抗体の用量および投与 |
| WO2020006266A1 (en) | 2018-06-28 | 2020-01-02 | Alexion Pharmaceuticals, Inc. | Methods of producing anti-c5 antibodies |
| US20210388070A1 (en) * | 2018-10-30 | 2021-12-16 | Alexion Pharmaceuticals, Inc. | Co-administration of a hyaluronidase and anti-c5 antibody for treatment of complement-associated conditions |
| CN112996561A (zh) | 2018-10-30 | 2021-06-18 | 亚力兄制药公司 | 用于治疗阵发性睡眠性血红蛋白尿症(pnh)的抗c5抗体的皮下剂量和施用 |
| KR102840400B1 (ko) | 2018-12-12 | 2025-08-04 | 카이트 파마 인코포레이티드 | 키메라 항원 수용체 및 car-t 세포 및 사용 방법 |
| AU2020232691B2 (en) | 2019-03-05 | 2023-06-29 | Nkarta, Inc. | CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| IL297538A (en) | 2020-04-24 | 2022-12-01 | Millennium Pharm Inc | Anti-cd19 antibodies and uses thereof |
| US20230277524A1 (en) | 2020-05-22 | 2023-09-07 | Trailhead Biosystems Inc. | Combination therapy for treatment of viral infections |
| WO2021252804A1 (en) | 2020-06-12 | 2021-12-16 | Nkarta, Inc. | Genetically modified natural killer cells for cd70-directed cancer immunotherapy |
| JP7829595B2 (ja) | 2021-04-09 | 2026-03-13 | 武田薬品工業株式会社 | 補体因子ｄを標的とする抗体及びその使用 |
| IL307940A (en) | 2021-04-26 | 2023-12-01 | Millennium Pharm Inc | Anti-ADGRE2 antibodies and their uses |
| PE20241789A1 (es) | 2021-04-26 | 2024-09-06 | Millennium Pharm Inc | Anticuerpos anti-clec12a y usos de los mismos |
| KR20240099161A (ko) | 2021-10-20 | 2024-06-28 | 다케다 야쿠힌 고교 가부시키가이샤 | Bcma를 표적화하는 조성물 및 이의 사용 방법 |
| CA3254363A1 (en) * | 2022-03-07 | 2023-09-14 | Nkarta, Inc. | Multiplex gene-edited cells for CD70-led cancer immunotherapy |
| WO2023198757A1 (en) | 2022-04-14 | 2023-10-19 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections |
| CN117100857B (zh) * | 2023-08-15 | 2024-09-10 | 福建医科大学附属协和医院 | 一种抗体金纳米笼载药系统、制备方法和用途 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4228795A (en) * | 1977-03-08 | 1980-10-21 | Babington Robert S | Apparatus for producing finely divided liquid spray |
| EP0530216A4 (en) * | 1990-04-19 | 1993-06-30 | Medimmune, Inc. | Administration of monoclonal antibodies against respiratory viruses |
| EP0539522B1 (en) * | 1990-07-19 | 1998-12-30 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Improved immunotherapeutic method of preventing or treating viral respiratory tract disease |
| US5871734A (en) * | 1992-01-13 | 1999-02-16 | Biogen, Inc. | Treatment for asthma with VLA-4 blocking agents |
| US5833989A (en) | 1992-06-24 | 1998-11-10 | Adprotech Plc | Soluble CR1 derivatives |
| US5614370A (en) * | 1994-03-18 | 1997-03-25 | Merck & Co., Inc. | Assay to identify human C5a antagonists and agonists |
| US6074642A (en) * | 1994-05-02 | 2000-06-13 | Alexion Pharmaceuticals, Inc. | Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis |
| US20010036650A1 (en) * | 1994-08-16 | 2001-11-01 | Human Genome Sciences, Inc. | C5a receptor |
| DE69534701T2 (de) | 1994-09-23 | 2006-10-19 | Alexion Pharmaceuticals, Inc., Cheshire | Verfahren zur behandlung von entzündlichen gelenkerkrankungen |
| US5728844A (en) * | 1995-08-29 | 1998-03-17 | Celgene Corporation | Immunotherapeutic agents |
| CA2265877A1 (en) * | 1996-09-10 | 1998-03-19 | Medinox, Inc. | Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications |
| EP0934341A1 (en) | 1996-10-28 | 1999-08-11 | Farmac Nederland B.V. | Inclusion complexes of beta-2-andrenergics for oral mucosal delivery |
| US7070799B1 (en) * | 1998-02-10 | 2006-07-04 | Generex Pharmaceuticals, Inc. | Method for administering insulin to the buccal region |
| US6956107B2 (en) * | 1998-02-20 | 2005-10-18 | Tanox, Inc. | Inhibitors of complement activation |
| US20020182260A1 (en) * | 1998-05-29 | 2002-12-05 | Cellegy Pharmaceuticals, Inc. | Anti-inflammatory agents and methods for their preparation and use |
| US6093743A (en) * | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| WO2000006152A1 (en) * | 1998-07-30 | 2000-02-10 | Novopharm Biotech, Inc. | Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
| US6280994B1 (en) * | 1998-11-25 | 2001-08-28 | Zymogenetics, Inc. | Zace 1: a human metalloenzyme |
| US6914128B1 (en) * | 1999-03-25 | 2005-07-05 | Abbott Gmbh & Co. Kg | Human antibodies that bind human IL-12 and methods for producing |
| US7109299B1 (en) * | 1999-12-16 | 2006-09-19 | Affymax, Inc. | Peptides and compounds that bind to the IL-5 receptor |
| EE200200426A (et) * | 2000-01-31 | 2003-12-15 | Pfizer Products Inc. | PDE4 isosüümide inhibiitoritena kasulikud pürimidiinkarboksamiidid |
| TWI335336B (https=) * | 2000-02-10 | 2011-01-01 | Abbott Gmbh & Co Kg | |
| AU2001249410A1 (en) * | 2000-03-23 | 2001-10-03 | Tanox, Inc. | Anti-c2/c2a inhibitors of complement activation |
| EP2206720A1 (en) * | 2000-04-12 | 2010-07-14 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7879328B2 (en) * | 2000-06-16 | 2011-02-01 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator |
| CA2413830A1 (en) * | 2000-06-21 | 2001-12-27 | Zymogenetics, Inc. | Peptide and polypeptide inhibitors of complement c1s |
| KR100919593B1 (ko) * | 2000-06-29 | 2009-09-29 | 아보트 러보러터리즈 | 이중 특이성 항체 및 이의 제조 방법 및 이를 포함하는 조성물 |
| NZ526720A (en) * | 2000-12-28 | 2007-11-30 | Altus Pharmaceuticals Inc | Crystallisation of whole antibodies or fragments thereof, on a large scale and a process allowing an alternative route for delivery of therapeutic antibodies |
| CA2440676A1 (en) * | 2001-03-22 | 2002-10-03 | Abbott Gmbh & Co. Kg | Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| US8178098B2 (en) * | 2001-04-03 | 2012-05-15 | National Jewish Health | Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies |
| AU2002316574B2 (en) * | 2002-03-15 | 2008-05-01 | Brandeis University | Central airway administration for systemic delivery of therapeutics |
| WO2003084524A1 (en) * | 2002-03-29 | 2003-10-16 | Neurogen Corporation | Combination therapy for the treatment of conditions with pathogenic inflammatory components |
| US20040219142A1 (en) | 2002-07-19 | 2004-11-04 | Abbott Laboratories S.A. | Treatment of skin and nail disorders using TNFalpha inhibitors |
| WO2004022096A1 (en) * | 2002-09-06 | 2004-03-18 | Alexion Pharmaceuticals, Inc. | Method of treatment of asthma using antibodies to complement component c5 |
| US20050271660A1 (en) | 2002-09-06 | 2005-12-08 | Alexion Pharmaceuticals, Inc. | Nebulization of monoclonal antibodies for treating pulmonary diseases |
| US9415102B2 (en) | 2002-09-06 | 2016-08-16 | Alexion Pharmaceuticals, Inc. | High concentration formulations of anti-C5 antibodies |
| US20030124139A1 (en) * | 2002-11-20 | 2003-07-03 | Irina Esikova | Compositions and methods for stabilizing biological molecules upon lyophilization |
| US7361339B2 (en) * | 2003-01-09 | 2008-04-22 | Alexion Pharmaceuticals, Inc. | Methods for reducing morality associated with acute myocardial infarction |
| RU2358763C2 (ru) * | 2003-02-10 | 2009-06-20 | Элан Фармасьютикалз, Инк. | Композиции иммуноглобулина и способ их получения |
| US20050026881A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease |
| US20050169921A1 (en) * | 2004-02-03 | 2005-08-04 | Leonard Bell | Method of treating hemolytic disease |
| CA2638811A1 (en) * | 2006-02-03 | 2007-08-16 | Medimmune, Llc | Protein formulations |
| PL3167888T3 (pl) | 2006-03-15 | 2024-08-26 | Alexion Pharmaceuticals, Inc. | Leczenie pacjentów z napadową nocną hemoglobinurią za pomocą inhibitora dopełniacza |
| CA2674608A1 (en) * | 2007-01-09 | 2008-07-17 | Wyeth | Anti-il-13 antibody formulations and uses thereof |
| JP4538514B2 (ja) | 2008-07-30 | 2010-09-08 | シャープ株式会社 | 画像圧縮方法、画像圧縮装置、画像形成装置、コンピュータプログラム及び記録媒体 |
| LT2894165T (lt) | 2008-11-10 | 2023-03-10 | Alexion Pharmaceuticals, Inc. | Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui |
| MX2011011772A (es) | 2009-05-04 | 2012-02-08 | Abbott Biotech Ltd | Formulaicones estables de anticuerpos humanos anti-tnf-alfa con alta concentracion de proteina. |
-
2005
- 2005-05-11 US US11/127,438 patent/US20050271660A1/en not_active Abandoned
-
2006
- 2006-05-10 WO PCT/US2006/018269 patent/WO2006122257A2/en not_active Ceased
- 2006-05-10 CA CA002608195A patent/CA2608195A1/en not_active Abandoned
- 2006-05-10 NZ NZ582627A patent/NZ582627A/en unknown
- 2006-05-10 JP JP2008511366A patent/JP2008540563A/ja not_active Withdrawn
- 2006-05-10 NZ NZ563509A patent/NZ563509A/en not_active IP Right Cessation
- 2006-05-10 AU AU2006243994A patent/AU2006243994B2/en not_active Ceased
- 2006-05-10 EP EP06759586A patent/EP1881993A2/en not_active Withdrawn
-
2012
- 2012-09-04 JP JP2012193985A patent/JP2012233013A/ja active Pending
-
2014
- 2014-06-19 JP JP2014125985A patent/JP2014169332A/ja active Pending
-
2017
- 2017-08-11 US US15/675,074 patent/US10125191B2/en not_active Expired - Lifetime
-
2018
- 2018-10-04 US US16/152,235 patent/US10479828B2/en not_active Expired - Lifetime
-
2019
- 2019-10-09 US US16/597,040 patent/US10927166B2/en not_active Expired - Lifetime
-
2021
- 2021-01-19 US US17/152,054 patent/US20210214427A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008540563A5 (https=) | ||
| Newman | Principles of metered-dose inhaler design | |
| JP2012528200A5 (https=) | ||
| JP2012528792A5 (https=) | ||
| HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
| JP2007520508A5 (https=) | ||
| RU2017144619A (ru) | Катионы одновалентных металлов сухих порошков для ингаляций | |
| HRP20220919T3 (hr) | Sastav za inhalaciju koji sadrži aklidinij za liječenje kronične opstruktivne bolesti pluća | |
| JP5800829B2 (ja) | Ｃｏｐｄ用エアロゾル製剤 | |
| JP2007522229A5 (https=) | ||
| RU2006132036A (ru) | Комбинация и фармацевтический препарат для лечения аллергий и заболеваний дыхательных путей | |
| JP2014510064A5 (https=) | ||
| HRP20050570A2 (en) | Powdered medicament for inhalation comprising a tiotropium salt and salmetrol xinafoate | |
| CN111936124A (zh) | 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用 | |
| CN102186458A (zh) | 治疗慢性阻塞性肺病及其它肺疾病的方法 | |
| JP2005532988A5 (https=) | ||
| JP2007528409A5 (https=) | ||
| JP2007527430A5 (https=) | ||
| CA2558426A1 (en) | Formulations decreasing particle exhalation | |
| JP2020023536A (ja) | Ｃｏｐｄの治療のためのフォルモテロール及びブデソニドの組み合わせ | |
| CN115768402A (zh) | 用于治疗急性肺损伤的5-氨基-2,3-二氢-1,4-酞嗪二酮 | |
| JP2007520507A5 (https=) | ||
| KR20220137051A (ko) | 염증성 폐질환의 흡입치료용 5-아미노-2,3-디히드로-1,4-프탈라진디온 | |
| US20130125882A1 (en) | Method and composition for treating asthma and copd | |
| HRP20160630T1 (hr) | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata |